Mark C. McKenna

Insider Reports History

Location
400 Somerset Corporate Boulevard, Bridgewater, NJ
Signature
/s/ Mark C. McKenna
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark C. McKenna:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apogee Therapeutics, Inc. Director Common Stock 20K $997K $49.85 Dec 12, 2024 Direct
BridgeBio Oncology Therapeutics, Inc. Former Director Common Stock 30K $322K $10.72 Aug 11, 2025 Direct
NewAmsterdam Pharma Co N.V. Director Ordinary Shares 6.96K $178K $25.54 Jan 7, 2025 Direct
NewAmsterdam Pharma Co N.V. Director Option (right to buy) 32.5K Jan 6, 2025 Direct
Spyre Therapeutics, Inc. Director Stock Option (Right to Buy) 25K May 29, 2025 Direct
Apogee Therapeutics, Inc. Director Stock Option (Right to Buy) 14.5K Jun 17, 2025 Direct
BridgeBio Oncology Therapeutics, Inc. Former Director Class B ordinary shares 0 Aug 11, 2025 Direct
Prometheus Biosciences, Inc. Chairman, President and CEO, Director Common Stock 0 $108.42 Jun 16, 2023 Direct
Prometheus Biosciences, Inc. Chairman, President and CEO, Director Stock Option (right to buy) 0 Jun 16, 2023 Direct

Insider Reports Filed by Mark C. McKenna

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBOT BridgeBio Oncology Therapeutics, Inc. Aug 11, 2025 2 $0 4 Aug 11, 2025 Former Director
APGE Apogee Therapeutics, Inc. Jun 17, 2025 1 $0 4 Jun 20, 2025 Director
SYRE Spyre Therapeutics, Inc. May 29, 2025 1 $0 4 Jun 2, 2025 Director
NAMS NewAmsterdam Pharma Co N.V. Jan 6, 2025 2 $0 4 Jan 8, 2025 Director
APGE Apogee Therapeutics, Inc. Dec 12, 2024 2 $991K 4 Dec 16, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Jul 17, 2024 1 $0 4 Jul 19, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Jul 16, 2024 0 $0 3 Jul 19, 2024 Director
PCSC Perceptive Capital Solutions Corp Jun 11, 2024 0 $0 3 Jun 11, 2024 Director
APGE Apogee Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
HLXB Helix Acquisition Corp. II Feb 8, 2024 0 $0 3 Feb 8, 2024 Director
SYRE Spyre Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 Director
SYRE Spyre Therapeutics, Inc. Feb 1, 2024 0 $0 3 Feb 5, 2024 Director
APGE Apogee Therapeutics, Inc. Aug 17, 2023 2 $0 4 Aug 21, 2023 Director
APGE Apogee Therapeutics, Inc. Aug 17, 2023 0 $0 3 Aug 21, 2023 Director
RXDX Prometheus Biosciences, Inc. Jun 16, 2023 9 $0 4 Jun 16, 2023 Chairman, President and CEO, Director
RXDX Prometheus Biosciences, Inc. Jun 2, 2023 4 $355K 4 Jun 2, 2023 Chairman, President & CEO, Director
RXDX Prometheus Biosciences, Inc. Mar 15, 2023 3 -$2.83M 4 Mar 17, 2023 Chairman, President & CEO, Director
RXDX Prometheus Biosciences, Inc. Mar 1, 2023 6 -$1.37M 4 Mar 3, 2023 Chairman, President & CEO, Director
RXDX Prometheus Biosciences, Inc. Feb 15, 2023 9 -$7.48M 4 Feb 17, 2023 Chairman, President & CEO, Director
RXDX Prometheus Biosciences, Inc. Jan 17, 2023 3 -$2.9M 4 Jan 19, 2023 Chairman, President & CEO, Director
RXDX Prometheus Biosciences, Inc. Dec 9, 2022 2 $0 4 Dec 13, 2022 Chairman, President & CEO, Director
RXDX Prometheus Biosciences, Inc. May 20, 2022 1 $0 4 May 20, 2022 Chairman, President & CEO, Director
RXDX Prometheus Biosciences, Inc. Dec 1, 2021 2 $44.7K 4 Dec 3, 2021 Chairman, President & CEO, Director
RXDX Prometheus Biosciences, Inc. Nov 14, 2021 1 $0 4 Nov 16, 2021 Chairman, President & CEO, Director